Berlin, Germany

Karsten Parzcyk


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karsten Parzcyk

Introduction

Karsten Parzcyk is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of selective estrogen compounds. His work has implications for various therapeutic applications, including hormone replacement therapy.

Latest Patents

Karsten Parzcyk holds a patent for "11&bgr;-aryl substituted 14,17-ethanoestratriens, method for the production of these compounds and their use in the production of medicaments." This invention describes 11&bgr;-aryl-substituted 14,17-ethanoestratrienes of general formula (I). The new compounds are selective estrogens whose action occurs in a tissue-selective manner. The estrogenic action occurs particularly on bone, in the cardiovascular system, and in the central nervous system. However, only a slight estrogenic action or no estrogenic action occurs in the uterus and liver. The compounds are suitable for the production of pharmaceutical agents for use in numerous indications, such as hormone replacement therapy and the prevention and treatment of osteoporosis.

Career Highlights

Karsten Parzcyk has had a distinguished career in the pharmaceutical industry. He is currently associated with Schering Aktiengesellschaft, where he continues to innovate and develop new medicinal compounds. His expertise in the field has led to advancements in therapeutic options for patients.

Collaborations

Throughout his career, Karsten has collaborated with esteemed colleagues, including Rolf Bohlmann and Karl Heinrich Fritzemeier. These collaborations have contributed to the success of his research and the development of new medicinal products.

Conclusion

Karsten Parzcyk's contributions to the field of medicinal chemistry are noteworthy. His innovative work on selective estrogens has the potential to improve treatment options for various health conditions. His career reflects a commitment to advancing medical science through invention and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…